News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Astellas Pharma US, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Policy
FDA Panel Backs Astellas Pharma Inc.'s CRESEMBA for Invasive Fungal Infections
January 22, 2015
·
2 min read
Business
SSF’s Cytokinetics, Inc. Snags $675 Million+ Deal With Astellas Pharma Inc.
December 23, 2014
·
2 min read
Business
Astellas Pharma Inc., Janssen Biotech Inc. To End Collaboration On RA Drug ASP015K
December 2, 2014
·
1 min read
Business
Ironwood Pharmaceuticals Earns $15 Million Milestone From Astellas Pharma Inc.
November 20, 2014
·
1 min read
Business
Astellas, Proteostasis Forge $1.2 Billion Genetic Disease Drug Pact
November 4, 2014
·
2 min read
Biotech Beach
The Day In Review: Novartis Corporation Pulls Zelnorm Off The Market
March 30, 2007
·
1 min read
Biotech Beach
The Day In Review: Crucell N.V. And Astellas Pharma Inc. Abandon Drugs
July 18, 2006
·
1 min read
Biotech Beach
The Day In Review: Biomira Inc. Cancer Drug Reports Positive Results
April 28, 2006
·
1 min read
Biotech Beach
The Day In Review: EpiCept Corporation Gains On Ceplene Success
March 31, 2006
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Business
University of Tokyo, Astellas Enter Second Phase of Strategic Partnership for Co-creation of Innovative New Medicines and Medical Solutions
April 25, 2022
·
5 min read
Policy
European Commission Approves PADCEV™ (enfortumab vedotin) for Locally Advanced or Metastatic Urothelial Cancer
April 13, 2022
·
8 min read
Business
Singlera Genomics announces research collaboration with Astellas Pharma pursuing methylation-based tools to better understand biological reactions to pharmaceuticals
April 5, 2022
·
1 min read
Drug Development
Astellas Announces Topline 12-week Results from Phase 3 Study of Fezolinetant for the Nonhormonal Treatment of Vasomotor Symptoms in Women in Asia
March 14, 2022
·
7 min read
Business
Genetic Leap and Astellas Establish Research Collaboration to Develop RNA-targeted Small Molecules for Oncology Target
March 10, 2022
·
1 min read
Genetown
Affinivax Reacquires Rights from Astellas for ASP3772, a Novel 24-valent Streptococcus pneumoniae Vaccine Candidate from Affinivax’s MAPS™ Platform
February 28, 2022
·
7 min read
BioForest
Astellas and Seagen Announce CHMP Confirms Positive Opinion for PADCEV™ (enfortumab vedotin) in Locally Advanced or Metastatic Urothelial Cancer
February 28, 2022
·
15 min read
Job Trends
Seagen and Astellas Announce Initial Results of PADCEV® (enfortumab vedotin-ejfv) in Patients With Muscle-Invasive Bladder Cancer Not Eligible for Cisplatin Chemotherapy
February 14, 2022
·
19 min read
Job Trends
Astellas and Seagen Announce Initial Results of PADCEV® (enfortumab vedotin-ejfv) in Patients With Muscle-Invasive Bladder Cancer Not Eligible for Cisplatin Chemotherapy
February 14, 2022
·
18 min read
Drug Development
Astellas Announces Positive Safety Data from the FORTIS Study of AT845 in Adults with Late-Onset Pompe Disease
February 7, 2022
·
8 min read
